PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
4.080
-0.070 (-1.69%)
Oct 29, 2024, 4:00 PM EDT - Market closed
PetMed Express Revenue
PetMed Express had revenue of $67.95M in the quarter ending June 30, 2024, a decrease of -13.15%. This brings the company's revenue in the last twelve months to $270.77M, up 2.26% year-over-year. In the fiscal year ending March 31, 2024, PetMed Express had annual revenue of $281.06M with 9.54% growth.
Revenue (ttm)
$270.77M
Revenue Growth
+2.26%
P/S Ratio
0.31
Revenue / Employee
$943,456
Employees
287
Market Cap
83.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 281.06M | 24.49M | 9.54% |
| Mar 31, 2023 | 256.58M | -15.70M | -5.77% |
| Mar 31, 2022 | 272.28M | -31.30M | -10.31% |
| Mar 31, 2021 | 303.58M | 19.46M | 6.85% |
| Mar 31, 2020 | 284.13M | 706.00K | 0.25% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cidara Therapeutics | 53.87M |
| DBV Technologies | 13.81M |
| Armata Pharmaceuticals | 3.72M |
| X4 Pharmaceuticals | 563.00K |
| Chimerix | 144.00K |
PETS News
- 4 weeks ago - PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - PetMed Express, Inc. (PETS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer - GlobeNewsWire
- 4 months ago - PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 5 months ago - PetMed Express, Inc. (PETS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results - GlobeNewsWire
- 5 months ago - PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team - GlobeNewsWire